Patent Applications published on Aug 28, 2025 - page 3

#601
US20250268715A1
Human necessities

MITRALLEAFLET TETHERING

#602
US20250268716A1
Human necessities

Responsive Biomechanical Implants and Devices

#603
US20250268717A1
Human necessities

SYSTEM AND METHOD FOR TREATMENT AND PREVENTION OF PERIPROSTHETIC JOINT INFECTIONS

#604
US20250268718A1
Human necessities

Apparatus and Methods for Small Joint and Bony Defect Replacement

#605
US20250268719A1
Human necessities

SHOULDER PROSTHESIS COMPONENTS AND ASSEMBLIES

#606
US20250268720A1
Human necessities

Implantable Non-Fusion Growth Modulating System

#607
US20250268721A1
Human necessities

LOCKING MECHANISM FOR JOINING BONES AND RELATED METHOD

#608
US20250268722A1
Human necessities

EXPANDABLE INTERVERTEBRAL IMPLANT

#609
US20250268723A1
Human necessities

SYSTEMS AND METHODS FOR FLEXURE-BASED STANDALONE INTERBODY FUSION

#610
US20250268724A1
Human necessities

INTERBODY FUSION DEVICES AND RELATED METHODS OF MANUFACTURE

#611
US20250268725A1
Human necessities

EXPANDABLE INTERVERTEBRAL IMPLANT BY CONICAL SCREW ELEMENT AND SYSTEM

#612
US20250268726A1
Human necessities

EXPANDABLE FUSION IMPLANT AND RELATED METHODS

#613
US20250268727A1
Human necessities

JOINT IMPLANT EXTRACTION AND PLACEMENT SYSTEM AND LOCALIZATION DEVICE USED THEREWITH

#614
US20250268728A1
Human necessities

SPINAL IMPLANT DEVICE

#615
US20250268729A1
Human necessities

Bone Preparation Device

#616
US20250268730A1
Human necessities

BREAST PROSTHETIC DEVICE, FASTENING SYSTEM, AND USES THEREOF

#617
US20250268731A1
Human necessities

PROSTHETIC LIMB WITH THERMO-ELECTRIC ACTUATOR

#618
US20250268732A1
Human necessities

ADJUSTABLE DEVICES AND RELATED SYSTEMS AND METHODS

#619
US20250268733A1
Human necessities

PROSTHETIC PYLON EMULATOR

#620
US20250268734A1
Human necessities

ENDOVASCULAR PROSTHESIS WITH SELECTIVELY OPENABLE INTERNAL DUCT

#621
US20250268735A1
Human necessities

SYSTEMS AND METHODS FOR MANUFACTURING A STENT FRAME

#622
US20250268736A1
Human necessities

VASCULAR STENT AND MANUFACTURING PROCESS THEREFOR

#623
US20250268737A1
Human necessities

REPOSITIONABLE AND REMOVABLE STENTS

#624
US20250268738A1
Human necessities

BALLOON CATHETER ASSEMBLY

#625
US20250268739A1
Human necessities

POSTURE CORRECTION BRACE

#626
US20250268740A1
Human necessities

CERVICAL IMMOBILIZATION DEVICE

#627
US20250268741A1
Human necessities

APPARATUS AND METHODS FOR RECEIVING DISCHARGED URINE

#628
US20250268742A1
Human necessities

URINE MANAGEMENT SYSTEMS AND METHODS

#629
US20250268743A1
Human necessities

OSTOMY APPLIANCE COUPLING ASSEMBLY

#630
US20250268744A1
Human necessities

Non-Invasive Female Catheter System

#631
US20250268745A1
Human necessities

MOBILE CRYOTHERAPY DEVICE

#632
US20250268746A1
Human necessities

TEMPERATURE THERAPY GARMENT AND METHOD

#633
US20250268747A1
Human necessities

Adjustable Therapy Wrap

#634
US20250268748A1
Human necessities

TREATMENT OF SPINAL MUSCULAR ATROPHY BY INDUCING HEAT SHOCK RESPONSE

#635
US20250268749A1
Human necessities

OCULAR DRUG DELIVERY DEVICES SECURELY IMPLANTABLE INTO ANTERIOR SEGMENT OF EYE

#636
US20250268750A1
Human necessities

PUNCTAL PLUG AND BIOADHESIVES

#637
US20250268751A1
Human necessities

INTRAOCULAR SHUNT IMPLANTATION

#638
US20250268752A1
Human necessities

INTRAOCULAR SYSTEMS, DEVICES, KITS, AND METHODS

#639
US20250268753A1
Human necessities

INTELLIGENT DETECTION AND TREATMENT OF ISCHEMIC TISSUE

#640
US20250268754A1
Human necessities

DYNAMIC SURGICAL FEEDBACK FOR EYE TISSUE

#641
US20250268755A1
Human necessities

HANDHELD FIBER PROBE FOR LASER TREATMENT OF MEDICAL TISSUE, IN PARTICULAR FOR TREATMENT OF GLAUCOMA

#642
US20250268756A1
Human necessities

Tissue-Augmented Corneal Inlay Surgery Technique

#643
US20250268757A1
Human necessities

OPHTHALMIC LASER TREATMENT DEVICE

#644
US20250268758A1
Human necessities

GOGGLE LENS REPLACEMENT STRUCTURE

#645
US20250268759A1
Human necessities

EYE MASK BODY, EYE MASK, AND PREPARATION METHOD THEREOF

#646
US20250268760A1
Human necessities

STRETCH TO FIT BANDAGE

#647
US20250268761A1
Human necessities

USER-CUSTOMIZABLE BANDAGE

#648
US20250268762A1
Human necessities

SHEAR RESISTANT WOUND DRESSING FOR USE IN VACUUM WOUND THERAPY

#649
US20250268763A1
Human necessities

Ankle Support Tape

#650
US20250268764A1
Human necessities

METHODS OF MANUFACTURING ZONED WEBS

#651
US20250268765A1
Human necessities

SANITARY ARTICLE WITH REMOVABLE LATERAL AND/OR END PORTIONS

#652
US20250268766A1
Human necessities

PANT-TYPE ABSORBENT ARTICLE AND MANUFACTURING METHOD THEREOF

#653
US20250268767A1
Human necessities

ELASTIC COVER FOR WEARABLE ARTICLE AND METHOD OF MAKING THEREOF

#654
US20250268768A1
Human necessities

ACTIVE PRESSURE RELIEVING SYSTEM

#655
US20250268769A1
Human necessities

VEHICLE

#656
US20250268770A1
Human necessities

PATIENT SUPPORT SURFACE HAVING A PNEUMATIC CONTROL ASSEMBLY

#657
US20250268771A1
Human necessities

NETWORK-ACCESSIBLE CONTROLLERS RESPONSIBLE FOR MANAGING PRESSURE-MITIGATION DEVICES AND APPROACHES TO INCORPORATING THE SAME INTO EXISTING INFRASTRUCTURE

#658
US20250268772A1
Human necessities

SYSTEMS AND METHODS FOR PATIENT POSITIONING

#659
US20250268773A1
Human necessities

DEVICE FOR CORRECTING POSTURE

#660
US20250268774A1
Human necessities

HEAD SUPPORT AND METHOD FOR USE OF THE HEAD SUPPORT FOR POSITIONING A PATIENT RELATIVE TO A SURGICAL FRAME

#661
US20250268775A1
Human necessities

SURGICAL SUPPORT SYSTEMS, DEVICES, AND METHODS

#662
US20250268776A1
Human necessities

WEARABLE DEVICE AND OPERATING METHOD THEREOF

#663
US20250268777A1
Human necessities

OPTIMIZED KNEE EXOSKELETON WITH TUNABLE COMPLIANCE FOR REHABILITATION AND ASSISTANCE

#664
US20250268778A1
Human necessities

Walking Assistance Apparatus

#665
US20250268779A1
Human necessities

Finger Massage Apparatus

#666
US20250268780A1
Human necessities

AUTONOMOUS POD SYSTEM

#667
US20250268781A1
Human necessities

CONTROL METHOD, DEVICE, TERMINAL, AND STORAGE MEDIUM OF EXTERNAL EAR NEGATIVE PRESSURE GENERATOR

#668
US20250268782A1
Human necessities

METHODS OF STIMULATION USING MULTIPLE VIBRATIONAL ASSEMBLIES

#669
US20250268783A1
Human necessities

APPARATUS AND METHOD FOR REDUCTION OF NEUROLOGICAL MOVEMENT DISORDER SYMPTOMS USING WEARABLE DEVICE

#670
US20250268784A1
Human necessities

CAPACITIVE CELL BASED DEFORMATION SENSING STRUCTURE

#671
US20250268785A1
Human necessities

REAL-TIME METHODS TO ENABLE PRECISION-GUIDED CPR TO IMPROVE NEUROLOGICAL OUTCOME AND PREDICT BRAIN DAMAGE AFTER ISCHEMIC INJURY AND REPERFUSION

#672
US20250268786A1
Human necessities

DETERMINING CHEST COMPRESSION DEPTH USING IMPEDANCE

#673
US20250268787A1
Human necessities

HOT AND COLD THERAPY SYSTEM

#674
US20250268788A1
Human necessities

NEEDLE ASSEMBLIES CONTAINING ORIENTED NEEDLES AND METHODS FOR PRODUCTION THEREOF

#675
US20250268789A1
Human necessities

PILL ORGANIZER

#676
US20250268790A1
Human necessities

Medication packaging

#677
US20250268791A1
Human necessities

Apparatus and System for Remote Medication-Adherence Monitoring

#678
US20250268792A1
Human necessities

Anaerobic Blood Storage Containers

#679
US20250268793A1
Human necessities

HEATING SYSTEM FOR CONTAINERS FOR PHARMACEUTICAL USE

#680
US20250268794A1
Human necessities

HOUSING FOR A FLEXIBLE CONTAINER

#681
US20250268795A1
Human necessities

METHOD FOR THAWING BIOLOGICALLY-DERIVED FROZEN MATERIAL BY VERY HIGH FREQUENCY ELECTROMAGNETIC WAVE IRRADIATION, CRYOPRECIPITATE PRODUCING METHOD, AND THAWING DEVICE

#682
US20250268796A1
Human necessities

PHARMACEUTICAL PRODUCTION FACILITY COMPRISING A MEASURING DEVICE

#683
US20250268797A1
Human necessities

SYSTEM AND METHOD FOR PRECISION ORAL MEDICATION DELIVERY BASED ON REAL-TIME HEALTH MONITORING

#684
US20250268798A1
Human necessities

GASTRIC SECRETION REINFUSION SYSTEM AND METHOD OF OPERATION

#685
US20250268799A1
Human necessities

MEDIUM FOR WATER-FREE ROOT CANAL DISINFECTANT WITH HIGH FLUIDITY, DISINFECTANT USING SAME, AND USE THEREOF

#686
US20250268800A1
Human necessities

WET WIPE

#687
US20250268801A1
Human necessities

DRY CREAMS AND TOPICAL DELIVERY SYSTEMS

#688
US20250268802A1
Human necessities

TEMPERATURE STABLE EMULSIONS

#689
US20250268803A1
Human necessities

SUNSCREEN PREPARATION

#690
US20250268804A1
Human necessities

FRAGRANCE COMPOSITIONS

#691
US20250268805A1
Human necessities

PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS

#692
US20250268806A1
Human necessities

PERSONAL CARE COMPOSITION WITH A MULTIFUNCTIONAL INGREDIENT

#693
US20250268807A1
Human necessities

ANTI-AGING PEPTIDE CONTAINING COSMETIC

#694
US20250268808A1
Human necessities

TOPICAL COMPOSITION AND METHOD OF USE

#695
US20250268809A1
Human necessities

BROAD-SPECTRUM PEPTOIDS FOR ORAL AND DENTAL HYGIENE, AND COMPOSITIONS AND METHODS OF USE THEREOF

#696
US20250268810A1
Human necessities

AERATED COSMETIC COMPOSITION

#697
US20250268811A1
Human necessities

DISPERSION COMPRISING A POLYMERIC PARTICLE, A STABILIZER BEARING A C9-C22 ALKYL GROUP, AN OIL AND WATER, AND PROCESS FOR TREATING KERATIN MATERIALS USING THE DISPERSION

#698
US20250268812A1
Human necessities

COSMETIC COMPOSITION FOR SKIN IMPROVEMENT

#699
US20250268813A1
Human necessities

ANTIPERSPIRANT/DEODORANT COMPOSITIONS

#700
US20250268814A1
Human necessities

SIMULATED VERNIX COMPOSITION AND EMULSION INCLUDING THE SAME

#701
US20250268815A1
Human necessities

TRANSDERMAL DELIVERY SYSTEMS FOR ADMINISTRATION OF HYDROPHILIC MOLECULES AND METHODS OF MAKING AND USING SAME

#702
US20250268816A1
Human necessities

EXTENDED-RELEASE FORMULATION CONTAINING CRESOL

#703
US20250268817A1
Human necessities

DRUG DELIVERY FORMULATIONS

#704
US20250268818A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES

#705
US20250268819A1
Human necessities

DEVICES AND METHODS FOR DELIVERING METHANE INHIBITING COMPOUNDS TO ANIMALS

#706
US20250268820A1
Human necessities

METHOD FOR MANUFACTURING AN INHALABLE POWDER COMPRISING VORICONAZOLE

#707
US20250268821A1
Human necessities

NINTEDANIB AND NINTEDANIB COMBINATION DRY POWDER COMPOSITIONS AND USES

#708
US20250268822A1
Human necessities

METHODS, APPARATUSES AND SYSTEMS FOR INSTILLING STEM CELLS AND PHARMACEUTICALS INTO THE HUMAN VENTRICULAR SYSTEM

#709
US20250268823A1
Human necessities

Aqueous Quetiapine Solutions

#710
US20250268824A1
Human necessities

METHODS FOR MAKING REDUCED PARTICLE SIZE COMPOUNDS

#711
US20250268825A1
Human necessities

DELIVERY SYSTEM USING ENGINEERED EXTRACELLULAR VESICLES

#712
US20250268826A1
Human necessities

IONIZABLE LIPIDOID COMPOSITIONS AND THERAPEUTIC USES THEREOF

#713
US20250268827A1
Human necessities

COMBINED MEDICINAL DRUG INCLUDING LIPOSOME COMPOSITION ENCOMPASSING TOPOTECAN OR SALT THEREOF AND DNA DAMAGE REPAIR INHIBITOR

#714
US20250268828A1
Human necessities

Lipid Nanoparticle Compositions for Delivering Circular Polynucleotides

#715
US20250268829A1
Human necessities

INHALED ANTIBACTERIAL FORMULATIONS FOR TREATING LUNG INFECTIONS

#716
US20250268830A1
Human necessities

SUSTAINED RELEASE INJECTABLE PHARMACEUTICAL FORMULATION OF LEVOTHYROXINE AND PROCESS FOR PREPARATION THEREOF

#717
US20250268831A1
Human necessities

COMPACT COMPOSITIONS COMPRISING ZINGIBERACEAE RHIZOMES FOR ACTIVE AND ADDITIVE APPLICATIONS AND MANUFACTURING METHOD THEREOF

#718
US20250268832A1
Human necessities

Pretomanid Compositions

#719
US20250268833A1
Human necessities

Zwitterionic Hydrogels and Methods of Making and Using Same for Protein Therapy

#720
US20250268834A1
Human necessities

IONIC LIQUID SALTS OF ACTIVE PHARMACEUTICAL INGREDIENTS

#721
US20250268835A1
Human necessities

PHARMACEUTICAL COMPOSITIONS

#722
US20250268836A1
Human necessities

MICROSPHERE FORMULATIONS COMPRISING MULTIPLE NON-IDENTICAL PEPTIDES AND METHODS FOR MAKING THE SAME

#723
US20250268837A1
Human necessities

COMPOSITION FOR PROMOTING ANGIOGENESIS COMPRISING EXTRACELLULAR VESICLES DERIVED FROM THREE-DIMENSIONAL SPHEROID-TYPE CELL AGGREGATE

#724
US20250268838A1
Human necessities

NANOPARTICLES WITH NON-COVALENTLY BOUND TARGETING MOIETIES FOR USE IN A THERAPEUTIC METHOD AND FOR NON-MEDICAL USE

#725
US20250268839A1
Human necessities

PROMOTING TRAINED IMMUNITY WITH THERAPEUTIC NANOBIOLOGIC COMPOSITIONS

#726
US20250268840A1
Human necessities

USE OF NANO-CARRIERS FOR DELIVERY OF ACTIVE AGENTS

#727
US20250268841A1
Human necessities

Trans-Epithelial Membrane Drug Delivery System

#728
US20250268842A1
Human necessities

Compositions for reducing oxidative stress

#729
US20250268843A1
Human necessities

METHODS OF TREATMENT OF OSTEOARTHRITIS WITH TRANSDERMAL CANNABIDIOL GEL

#730
US20250268844A1
Human necessities

ANTICANCER AGENTS BASED ON CYCLOPENTENONES

#731
US20250268845A1
Human necessities

BONE REGENERATION COMPOSITION INCLUDING HORDENINE AND USE THEREOF

#732
US20250268846A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES AND DISORDERS

#733
US20250268847A1
Human necessities

METHODS AND COMPOSITIONS FOR THE TREATMENT OF DEMYELINATING DISORDERS

#734
US20250268848A1
Human necessities

COMPOSITIONS COMPRISING ENDOSIDIN 2 FOR REDUCING SARS-COV-2 INFECTION

#735
US20250268849A1
Human necessities

TREATMENT OF LOW-GRADE GLIOMA WITH MIRDAMETINIB

#736
US20250268850A1
Human necessities

NON-LINEAR DOSING OF MIRDAMETINIB

#737
US20250268851A1
Human necessities

SHORT CHAIN FATTY ACID COMPOUNDS AND USES THEREOF

#738
US20250268852A1
Human necessities

MICROBIOTA IMPROVING AGENT

#739
US20250268853A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING EDEMA REFRACTORY TO ORAL DIURETICS

#740
US20250268854A1
Human necessities

2-AMINO-5,5-DIMETHYLHEXANOIC ACID DERIVATIVES AS SORTILIN MODULATORS FOR USE IN THE TREATMENT OF DISEASE OF THE CENTRAL NERVOUS SYSTEM

#741
US20250268855A1
Human necessities

PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS WITH A COMBINATION OF AMINO ACIDS AND ITS USE IN DISEASES CHARACTERIZED BY LIPID ACCUMULATION IN TISSUES

#742
US20250268856A1
Human necessities

Pain Relieving Method

#743
US20250268857A1
Human necessities

METHOD AND DEVICE FOR INFECTION PREVENTION

#744
US20250268858A1
Human necessities

Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep

#745
US20250268859A1
Human necessities

OXAFURAMINE, (1R)-N-ETHYL-1-[(2R)-OXOLAN-2-YL]-2-PHENYLETHANAMINE, HYDROCHLORIDE AND DERIVATIVES THEREOF FOR TREATING ALZHEIMER'S DISEASE (AD), VASCULAR DEMENTIA, DEMENTIA WITH LEWY BODIES (DLB), MIXED DEMENTIA, FRONTOTEMPORAL LOBAR DEGENERATION (FTLD), AND PARKINSON'S DISEASE (PD)

#746
US20250268860A1
Human necessities

COMPOSITION FOR USE IN THE CUTANEOUS SYNTHESIS OF HYALURONIC ACID, IN AN IMMUNO-CUTANEOUS RESPONSE AND TO IMPROVE SKIN

#747
US20250268861A1
Human necessities

N-ACYLATED FATTY AMINO ACIDS TO REDUCE ABSORPTION VARIABILITY IN CANNABINOID BASED COMPOSITIONS

#748
US20250268862A1
Human necessities

POTASSIUM-COMPETITIVE ACID BLOCKERS FOR THE TREATMENT OF PATHOLOGICAL HYPERSECRETORY CONDITIONS

#749
US20250268863A1
Human necessities

DOSING REGIMENS FOR TREATMENT OF PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA

#750
US20250268864A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF EDARAVONE AND METHOD OF ADMINISTERING SAME

#751
US20250268865A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE

#752
US20250268866A1
Human necessities

Nasal Compositions and Method of Use Thereof

#753
US20250268867A1
Human necessities

OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND USES RELATING THERETO

#754
US20250268868A1
Human necessities

AGENT FOR REDUCING VISCERAL FAT WEIGHT

#755
US20250268869A1
Human necessities

METHODS OF USING A (THIAZOLYL)BENZENESULFONAMIDE DERIVATIVE

#756
US20250268870A1
Human necessities

SMALL MOLECULE INDUCERS OF CARDIOMYOCYTES TO IMPROVE CARDIAC STRUCTURE AND FUNCTION

#757
US20250268871A1
Human necessities

NEW CRYSTAL FORM OF NITROGEN-CONTAINING TRICYCLIC COMPOUND AND USE THEREOF

#758
US20250268872A2
Human necessities

ESTROGEN-RELATED RECEPTOR ALPHA MODULATORS

#759
US20250268873A1
Human necessities

COMBINATION OF DUAL ATM AND DNA-PK INHIBITORS AND IMMUNOTHERAPEUTIC AGENTS FOR USE IN CANCER THERAPY

#760
US20250268874A1
Human necessities

MALEATE OF NICOTINYL ALCOHOL ETHER DERIVATIVE, CRYSTAL FORM THEREOF, AND APPLICATION THEREOF

#761
US20250268875A1
Human necessities

STABILIZED PHARMACEUTICAL COMPOSITION OF 1,4-DIHYDROPYRIDINES WITH HYDROGEN ATOM TRANSFER (HAT) ANTIOXIDANTS

#762
US20250268876A1
Human necessities

TREATMENT OF HIDRADENITIS SUPPURATIVA WITH ORISMILAST

#763
US20250268877A1
Human necessities

2H-INDAZOLE DERIVATIVES AS IRAK4 INHIBITORS AND THEIR USE IN THE TREATMENT OF DISEASE

#764
US20250268878A1
Human necessities

FERROPORTIN-INHIBITORS FOR THE USE IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS)

#765
US20250268879A1
Human necessities

METHODS OF TREATING NEUROLOGICAL, METABOLIC, AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED PIOGLITAZONE

#766
US20250268880A1
Human necessities

3-(Hydroxy)-Pyridin-4(1H)-One Compounds and Methods of Making and Using the Same

#767
US20250268881A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF APIXABAN

#768
US20250268882A1
Human necessities

NEUROPATHIC AND CHRONIC PAIN FORMULATIONS

#769
US20250268883A1
Human necessities

THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING MOVEMENT DISORDERS

#770
US20250268884A1
Human necessities

Deuterated Domperidone for Treating Gastroparesis

#771
US20250268885A1
Human necessities

ORAL COMPOSITION COMPRISING NICOTINAMIDE

#772
US20250268886A1
Human necessities

NEW FORMULATION OF ATROPINE

#773
US20250268887A1
Human necessities

THERAPEUTIC USES OF BRADYKININ B2-RECEPTOR ANTAGONISTS

#774
US20250268888A1
Human necessities

BRONCHODILATORS FOR TREATING OBSTRUCTIVE LUNG DISEASE

#775
US20250268889A1
Human necessities

COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS

#776
US20250268890A1
Human necessities

COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS

#777
US20250268891A1
Human necessities

BUPROPION DOSAGE FORMS WITH REDUCED FOOD AND ALCOHOL DOSING EFFECTS

#778
US20250268892A1
Human necessities

TREATMENT OF CANCER USING ARIPIPRAZOLE AND ANTICANCER AGENT

#779
US20250268893A1
Human necessities

PHARMACEUTICAL COMPOSITIONS

#780
US20250268894A1
Human necessities

MACROCYCLE COMPOUNDS FOR THE TREATMENT OF CANCER

#781
US20250268895A1
Human necessities

Crystalline Forms of a BTK Inhibitor

#782
US20250268896A1
Human necessities

LIQUID COMPOSITIONS

#783
US20250268897A1
Human necessities

USE OF HETEROCYCLIC COMPOUND IN TREATING DISEASES RELATED TO KINASE DRUG-RESISTANT MUTATION AND METHOD THEREFOR

#784
US20250268898A1
Human necessities

METHODS OF TREATING SYNOVIAL SARCOMA PATHOGENESIS BY SUMO2 INHIBITION

#785
US20250268899A1
Human necessities

ELACESTRANT IN COMBINATION WITH ABEMACICLIB IN WOMEN WITH BREAST CANCER

#786
US20250268900A1
Human necessities

COMBINATION THERAPY USING A SUBSTITUTED PYRIMIDIN-4(3H)-ONE AND NIVOLUMAB AS WELL AS ITS USE IN THE TREATMENT OF CANCER

#787
US20250268901A1
Human necessities

CRYSTAL FORM OF AZETIDINE-SUBSTITUTED COMPOUND

#788
US20250268902A1
Human necessities

THERAPEUTIC METHODS

#789
US20250268903A1
Human necessities

RXFP1 AGONISTS

#790
US20250268904A1
Human necessities

THERAPEUTICS AGAINST PATHOGENIC CORONAVIRUSES

#791
US20250268905A1
Human necessities

SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR

#792
US20250268906A1
Human necessities

MOLECULAR GLUE COMPOUND BASED ON CEREBLON PROTEIN DESIGN AND USE THEREOF

#793
US20250268907A1
Human necessities

MACROCYCLIC DERIVATIVE AND USE THEREOF

#794
US20250268908A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

#795
US20250268909A1
Human necessities

Combination Therapy

#796
US20250268910A1
Human necessities

NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

#797
US20250268911A1
Human necessities

Methods of Using RHO Kinase Inhibitors to Treat Alzheimer's Disease

#798
US20250268912A1
Human necessities

USE OF GABAA RECEPTOR MODULATORS FOR TREATMENT OF ITCH

#799
US20250268913A1
Human necessities

PKC INHIBITORS FOR THE TREATMENT OF SEPTIC CHOLESTASIS WITH CTM TARGETING

#800
US20250268914A1
Human necessities

FLUTICASONE DELIVERY COMPOSITIONS, DEVICES AND METHODS

#801
US20250268915A1
Human necessities

METHODS AND COMPOSITIONS FOR TESTOSTERONE PRODUCTION

#802
US20250268916A1
Human necessities

METHOD OF TREATING CNS DISORDERS WITH NEUROSTEROIDS AND GABAERGIC COMPOUNDS

#803
US20250268917A1
Human necessities

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREVENTION AND/OR TREATMENT OF INFLAMMATION

#804
US20250268918A1
Human necessities

METHODS FOR MAKING REDUCED PARTICLE SIZE COMPOUNDS

#805
US20250268919A1
Human necessities

COMPOUNDS FOR THE TREATMENT OF CANCER

#806
US20250268920A1
Human necessities

USE OF ANDROGEN RECEPTOR-MEDIATED MECHANISMS IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA

#807
US20250268921A1
Human necessities

OPTHALMIC FORMULATIONS AND USES THEREOF

#808
US20250268922A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING ACETYLSALICYLIC ACID AND PROTON PUMP INHIBITOR

#809
US20250268923A1
Human necessities

APPLICATION OF TETRACYCLINE COMPOUND IN TREATMENT OF TUMOR

#810
US20250268924A1
Human necessities

PROCESS FOR CREATING A CANNABINOID PICO-EMULSION WITH ANTIBIOTIC PROPERTIES AND THE RESULTING PICO-EMULSION

#811
US20250268925A1
Human necessities

METHODS OF TREATING MEDICAL CONDITIONS AND INHIBITING LINE1 REVERSE TRANSCRIPTASE USING A SUBSTITUTED ADENINYL-PROPYLOXY PHOSPHONIC ACID OR RELATED COMPOUND

#812
US20250268926A1
Human necessities

METHOD AND COMPOSITION FOR TREATING, ALLEVIATING OR PREVENTING A DISEASE OR CONDITION CAUSED BY AIR POLLUTANT

#813
US20250268927A1
Human necessities

SYNBIOTIC TREATMENT REGIMENS

#814
US20250268928A1
Human necessities

USE OF BACTERIORUBERINS AND GLYCOSYL DERIVATIVES THEREOF TO PREVENT AND TREAT DISEASES INVOLVING DYSREGULATED PROTEIN AGGREGATION, SUCH AS NEURODEGENERATIVE DISEASES

#815
US20250268929A1
Human necessities

TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS

#816
US20250268930A1
Human necessities

COMPOSITIONS AND METHODS FOR RESTORING OR INCREASING TISSUE PERFUSION

#817
US20250268931A1
Human necessities

TRANSCRIPTIONAL INHIBITOR FOR IMMUNE-RELATED GENE

#818
US20250268932A1
Human necessities

Oxygen-containing preparation for treating acne and wounds, a preparation method and an application device thereof

#819
US20250268933A1
Human necessities

COMPOSITION AND METHOD FOR TREATING HEARING LOSS

#820
US20250268934A1
Human necessities

Compositions and Methods for the Treatment of Bacterial Vaginosis

#821
US20250268935A1
Human necessities

Tumor Treatment

#822
US20250268936A1
Human necessities

ANIMAL FOOD COMPOSITIONS CONTAINING A COMBINATION OF SPRAY-DRIED PLASMA AND FRUCTO-OLIGOSACCHARIDES

#823
US20250268937A1
Human necessities

ENGINEERED IMMUNE CELLS TO TARGET SARS-COV2

#824
US20250268938A1
Human necessities

SMALL MOLECULE-REGULATED CELL SIGNALING EXPRESSION SYSTEM

#825
US20250268939A1
Human necessities

Chimeric Antigen Receptor Molecule for Specifically Recognizing Baff-R and Application of Chimeric Antigen Receptor Molecule

#826
US20250268940A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR COMPOSITIONS AND USES

#827
US20250268941A1
Human necessities

BCMA/CD19 CAR FOR TREATING MULTIPLE MYELOMA

#828
US20250268942A1
Human necessities

ISOLATED IMMUNE CELL EXPRESSING A RECEPTOR, INTERLEUKIN-7, AND CHEMOKINE (C-C MOTIF) LIGAND 19

#829
US20250268943A1
Human necessities

STEM CELL-DERIVED EXTRACELLULAR VESICLES AND METHODS OF USE THEREOF

#830
US20250268944A1
Human necessities

STROMAL STEM CELL THERAPEUTICS AND METHODS OF USE

#831
US20250268945A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING OSTEOARTHRITIS

#832
US20250268946A1
Human necessities

USE OF EXTRACT FROM RABBIT SKIN INFLAMED BY VACCINIA VIRUS IN TREATMENT OF ALZHEIMER'S DISEASE

#833
US20250268947A1
Human necessities

GENERATION OF ALVEOLAR EPITHELIAL TYPE 1 (AT1) CELLS

#834
US20250268948A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING POST ACUTE SEQUELAE OF SARS-COV-2 INFECTION (LONG COVID)

#835
US20250268949A1
Human necessities

IMMUNE CELL INHIBITION BY IMMUNE CHECKPOINT ENGAGERS

#836
US20250268950A1
Human necessities

PRENATAL SUPPLEMENT

#837
US20250268951A1
Human necessities

THERAPEUTIC AND PROPHYLACTIC USE OF MICROORGANISMS

#838
US20250268952A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING DETERIORATION IN BRAIN FUNCTION OR MAINTAINING OR IMPROVING BRAIN FUNCTION

#839
US20250268953A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING DISEASE II

#840
US20250268954A1
Human necessities

Treatment and/or Prevention of Digestive Disorder by a Bacterial Composition of Propionibacterium Freudenreichii and Bifidobacterium Longum

#841
US20250268955A1
Human necessities

MICROBIAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES

#842
US20250268956A1
Human necessities

COMPOSITIONS CONTAINING INDOLE-DERIVED METABOLITES AND METHODS OF USE THEREOF

#843
US20250268957A1
Human necessities

Ingestible Nutritive Compositions With Prebiotics, Probiotics, and Postbiotics

#844
US20250268958A1
Human necessities

COMMENSAL BACTERIA PROMOTE ENDOCRINE-RESISTANCE IN PROSTATE CANCER VIA ANDROGEN BIOSYNTHESIS

#845
US20250268959A1
Human necessities

COMPOSITIONS CONTAINING INDOLE-DERIVED METABOLITES AND METHODS OF USE THEREOF

#846
US20250268960A1
Human necessities

COMPOSITION FOR PREVENTION AND TREATMENT OF OBESITY OR INSULIN RESISTANCE SYNDROME COMPRISING LACTOBACILLUS PLANTARUM HAC03 AND RUTIN

#847
US20250268961A1
Human necessities

MODIFIED MICROORGANISMS EXPRESSING SagA AND RELATED COMPOSITIONS FOR IMMUNOMODULATION AGAINST INFECTION AND CANCER IMMUNOTHERAPY

#848
US20250268962A1
Human necessities

COMPOSITION FOR INFLAMMATORY BOWEL DISEASE

#849
US20250268963A1
Human necessities

SYNTHETIC VIRUSES

#850
US20250268964A1
Human necessities

PROCESS FOR PREPARING METABOLIZED CONDITIONED GROWTH MEDIA

#851
US20250268965A1
Human necessities

CHAGA MUSHROOM-RELATED FORMULATIONS, CHEMICAL COMPOUNDS, AND METHODS OF PRODUCTION AND USE THEREOF

#852
US20250268966A1
Human necessities

METHOD AND COMPOSITION FOR ENHANCING IMMUNE SYSTEM

#853
US20250268967A1
Human necessities

NUTRACEUTICAL COMPOUNDS USEFUL IN THE TREATMENT OF CORONAVIRUS DISEASE

#854
US20250268968A1
Human necessities

Vaporized Medicants and Methods of Use

#855
US20250268969A1
Human necessities

OPHTHALMIC COMPOSITION

#856
US20250268970A1
Human necessities

PROCESS TO ENHANCE THE BIOACTIVITY OF ASHWAGANDHA EXTRACTS

#857
US20250268971A1
Human necessities

SAFFRON AS ANTI-INFLAMMATORY AGENT IN TREATING INFLAMMATORY BOWEL DISEASE

#858
US20250268972A1
Human necessities

5a-REDUCTASE INHIBITOR

#859
US20250268973A1
Human necessities

GINGER EXTRACT POLYSACCHARIDE COMPOSITION AND METHOD OF SUPPORTING THE IMMUNE SYSTEM

#860
US20250268974A1
Human necessities

COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF

#861
US20250268975A1
Human necessities

PEPTOIDS FOR TREATING FILOVIRIDAE INFECTIONS

#862
US20250268976A1
Human necessities

BROAD-SPECTRUM PEPTOIDS FOR TREATMENT OR PREVENTION OF WOUND INFECTIONS, AND COMPOSITIONS AND METHODS OF USE THEREOF

#863
US20250268977A1
Human necessities

COMPOSITIONS AND METHODS FOR PROTECTING TYPE 2 ALVEOLAR EPITHELIAL CELLS (AEC2)

#864
US20250268978A1
Human necessities

TOPICAL CREAM AND METHOD OF USE

#865
US20250268979A1
Human necessities

COMBINATION OF MACROCYCLIC CFTR MODULATORS WITH CFTR CORRECTORS AND / OR CFTR POTENTIATORS

#866
US20250268980A1
Human necessities

AN ANTICANCER THERAPY TARGETING RAS AND OTHER ONCOGENIC SIGNALS BY INHIBITION OF DYNAMIC BLEBBING AND/OR SEPTINS

#867
US20250268981A1
Human necessities

METHODS AND COMPOSITIONS FOR MODULATION OF TAU PROTEINS

#868
US20250268982A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT AND/OR PROPHYLAXIS OF PROTEINOPATHIES

#869
US20250268983A1
Human necessities

Use of a VEGF Antagonist to Treat Angiogenic Eye Disorders

#870
US20250268984A1
Human necessities

INTERFERON-BASED CANCER TREATMENT METHOD, AND PHARMACEUTICAL COMBINATION

#871
US20250268985A1
Human necessities

BCL2 INHIBITOR AND PEPTIDE COMBINATION THERAPY FOR TREATING PROLIFERATIVE DISEASES

#872
US20250268986A1
Human necessities

GLP-1 PRODRUGS AND USES THEREOF

#873
US20250268987A1
Human necessities

FORMULATIONS

#874
US20250268988A1
Human necessities

PTH Prodrugs

#875
US20250268989A1
Human necessities

TREATMENT AND PREVENTION OF OSTEOPOROSIS IN HIGH BODY MASS INDEX INDIVIDUALS

#876
US20250268990A1
Human necessities

METHODS OF INDUCING IMMUNE TOLERANCE TO CLOTTING FACTORS

#877
US20250268991A1
Human necessities

FOOD COMPOSITION FOR SUPPRESSING MUSCLE FATIGUE AND/OR SUDDEN MUSCLE PAIN

#878
US20250268992A1
Human necessities

METHODS FOR TREATING DILATED CARDIOMYOPATHY AND PHARMACEUTICAL COMPOSITIONS THEREFOR

#879
US20250268993A1
Human necessities

ALKALINE PHOSPHATE-BASED ONCOLOGY TREATMENTS

#880
US20250268994A1
Human necessities

Optimized Nucleotide Sequences Encoding the Extracellular Domain of Human ACE2 Protein or a Portion Thereof

#881
US20250268995A1
Human necessities

COMPOSITIONS FOR BREAKDOWN OF GLUTEN PROTEINS

#882
US20250268996A1
Human necessities

METHODS OF AND COMPOSITIONS FOR TREATMENT OF UPPER LIMB SPASTICITY

#883
US20250268997A1
Human necessities

A Subunit Cryptococcus Vaccine

#884
US20250268998A1
Human necessities

METHODS OF TREATMENT FOR CANDIDA AURIS INFECTIONS

#885
US20250268999A1
Human necessities

Treatment and Prophylaxis of Amyloidosis

#886
US20250269000A1
Human necessities

ANTI-TUMOUR RESPONSES TO CYTOKERATINS

#887
US20250269001A1
Human necessities

METHODS TO STIMULATE IMMUNE RESPONSES TO MUTANT RAS USING ANUCLEATE CELLS

#888
US20250269002A1
Human necessities

CTA VACCINE CASSETTES

#889
US20250269003A1
Human necessities

NANO-ENHANCED VACCINE

#890
US20250269004A1
Human necessities

ENTEROCOCCUS FAECALIS VACCINE AND USES THEREOF

#891
US20250269005A1
Human necessities

METHODS FOR TREATING, AMELIORATING OR PREVENTING INFECTIONS USING DRUG AND VACCINATION COMBINATION TREATMENT

#892
US20250269006A1
Human necessities

METHODS FOR PREDICTING EFFICACY OF A MODIFIED LIVE PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) VACCINE

#893
US20250269007A1
Human necessities

NUCLEIC ACID MOLECULES AND USES THEREOF

#894
US20250269008A1
Human necessities

VACCINATION OF IMMUNOCOMPROMISED SUBJECTS

#895
US20250269009A1
Human necessities

VACCINE COMPOSITION FOR NOVEL CORONAVIRUS INFECTION

#896
US20250269010A1
Human necessities

NOVEL NUCLEIC ACID MOLECULE

#897
US20250269011A1
Human necessities

TREATMENT OF CANCER USING MRNA-MEDIATED VIRUS VACCINATION ANTIGENS DELIVERED BY ATTENUATED BACTERIA

#898
US20250269012A1
Human necessities

VIRUS ENCODING TRANSGENES TO COMPLEMENT CELLULAR THERAPY

#899
US20250269013A1
Human necessities

IMMUNOGENIC COMPOSITIONS FOR TREATMENT OF HEPATITIS B

#900
US20250269014A1
Human necessities

POLYSACCHARIDES FOR USE IN TREATING SARS-COV-2 INFECTIONS